• Home
  • Deal Card – Pyxa

The Transaction

Delancey Street Partners is pleased to announce the following transaction:

March 2019
Pyxa Solutions, LLC

Merger with Red Nucleus Enterprises, LLC
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to Pyxa Solutions, LLC

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to Pyxa Solutions, LLC (“Pyxa” or the “Company”) on its merger with Red Nucleus Enterprises, LLC (“Red Nucleus”), a portfolio company of Renovus Capital Partners (“Renovus”). Delancey Street helped the Company explore and evaluate its strategic alternatives; managed a highly selective sell-side M&A process; and structured and negotiated the terms of the transaction.

Pyxa is a specialized provider of cross-functional R&D services and solutions stemming from Regulatory Affairs. With deep industry expertise, its subject matter experts work hand-in-hand with their Life Science clients to strategically resolve global R&D challenges and mitigate compliance risk. From global experience in submissions, system implementation, information management, labeling and business transformation excellence, their solutions improve efficiency, streamline operations and enhance productivity. The Pyxa team prides itself on a collaborative approach that instills and reinforces industry best practices in every project delivered. Pyxa was founded in 2012 and is headquartered in Malvern, Pennsylvania.

Red Nucleus is premier provider of award-winning e-learning, digital content and performance solutions for the Life Sciences industry. From its offices in the US, UK, and India, Red Nucleus develops innovative solutions that engage and inspire client-facing teams throughout their continuing education journey. With a science-first focus, its solutions are designed to boost the clinical knowledge base of end users. Red Nucleus works exclusively within the Life Sciences and therefore its team intimately understands the Pharma business model, products, processes and challenges. The Red Nucleus team consists of more than 140 full-time employees whose commitment to creativity, quality and on-time delivery is unrivaled in the space.

Founded in 2010, Renovus Capital Partners is a Wayne, Pa based education, training and human capital focused private equity firm.  Renovus is based outside of Philadelphia and manages over $500 million of committed capital. To date, the firm has acquired 20 portfolio companies in areas such as technology services, educational content, classroom instruction, corporate training, and human capital. 

The transaction was completed March 11, 2019.

The principals of Delancey Street Partners have significant experience serving the Healthcare industry. To learn about our experience in Healthcare, please click here.

For additional information about this transaction, please contact:

B. Andrew Schmucker
Managing Partner

Delancey Street Partners

Our offices are located in the suburbs of Philadelphia:
Five Tower Bridge, Suite 420 | 300 Barr Harbor Drive | West Conshohocken, PA 19428
(484) 533-6300

© 2017 Delancey Street Partners, LLC | Disclosures

Securities offered through DSP Securities, LLC. Member SIPC | Member FINRA, all other transactions effectuated through Delancey Street Partners, LLC

Check the background of this investment professional on FINRA’s BrokerCheck »